Dror Bashan Net Worth & Insider Trades

Dror Bashan - President and CEO, Protalix Biotherapeutics, Inc

As of August 17, 2023

What is Dror Bashan's Net Worth?

The current estimated net worth of Protalix Biotherapeutics, Inc's President and CEO, Dror Bashan, is estimated to be about $886.9K . Dror Bashan owns about 1,153,458 units of Protalix Biotherapeutics, Inc common stock. In the last 4 years at Protalix Biotherapeutics, Inc, Dror Bashan has sold an estimated value of $0 worth.

What is Dror Bashan's Past Insider Trading?

Dror Bashan's largest purchase order was 68,000 units , worth over $102K on April 13, 2022. In total, Dror Bashan has made about 6 transactions over 4 years of their time at Protalix Biotherapeutics, Inc. Dror Bashan usually trades in August, with the busiest year in 2022.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Dror Bashan's' Mailing Address?

  • Mailing address is 2 Snunit St Science Park, Pob 455 Carmiel L3 L3 20100 Israel

What are Protalix Biotherapeutics, Inc's Past Insider Trades?

Protalix Biotherapeutics, Inc's most recent insider trade came on January 5, 2023 by Aharon Schwartz who bought 110,000 units worth $155.81K . In the last 16 years, insiders at Protalix Biotherapeutics, Inc have sold an estimated value of $74.99M and bought an estimated value of $6.11M worth of shares. Insider trading is most common in September, with the busiest year in 2009. The most active traders at the company are Yoseph Shaaltiel, Executive VP,  Al Et MD Phillip Frost,  and Trust Investments Gamma Frost .

Protalix BioTherapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...